Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News MPS North America acquires AJE LLC to enhance AI capabilities and expand into B2C marketplace In a significant development for the publishing industry, MPS North America LLC, a wholly owned subsidiary of MPS… byPallavi MadhirajuFebruary 29, 2024